Wenwen Li

ORCID: 0000-0001-9806-5045 · 5 papers in corpus
observational 2025
Medicine ·doi:10.1097/md.0000000000044941

The Levonorgestrel-releasing Intrauterine System (LNG-IUS) is extensively utilized in the treatment of adenomyosis. However, the displacement and expulsion of the LNG-IUS bring significant challenges. This was a retrospective analysis compa…

review 2025
Stem cell reviews and reports ·doi:10.1007/s12015-024-10833-0

Organoids are rapidly self-organizing 3D in vitro cultures derived from pluripotent stem cells (PSCs) or adult stem cells (ASCs) that possess disease-like characteristics with high success rates. Due to their ability to retain tissue struct…

lab-animal 2024
Regenerative therapy ·doi:10.1016/j.reth.2024.03.030

INTRODUCTION: Cell transplantation is an emerging and effective therapeutic approach for enhancing uterine adhesions caused by endometrial damage. Currently, human umbilical cord blood mononuclear cells (HUCBMCs) have been extensively for t…

lab-animal 2020
Drug design, development and therapy ·doi:10.2147/dddt.s262816

PURPOSE: To explore the exact mechanism through which emodin down-regulates the migration and invasion abilities of endometrial stromal cells. Moreover, to explore the theoretical basis of emodin in the treatment of endometriosis. PATIENTS…

observational 2018
Aging ·doi:10.18632/aging.101461

Copy number variations (CNVs) have been shown to cause numerous diseases, however, their roles in human lifespan remain elusive. In this study, we investigate the association of CNVs with longevity by comparing the Han Chinese genomes of lo…